Silva J, de Castro Alves C, Pontes G
Front Immunol. 2024; 15:1297994.
PMID: 38384471
PMC: 10879370.
DOI: 10.3389/fimmu.2024.1297994.
Hoseinnezhad T, Soltani N, Ziarati S, Behboudi E, Mousavi M
J Clin Lab Anal. 2024; 38(1-2):e25005.
PMID: 38251811
PMC: 10829690.
DOI: 10.1002/jcla.25005.
Vescovo S, Venerito V, Iannone C, Lopalco G
Int J Mol Sci. 2023; 24(7).
PMID: 37047435
PMC: 10095023.
DOI: 10.3390/ijms24076463.
Yin Y, Reed E, Zhang Q
Sci Rep. 2019; 9(1):8067.
PMID: 31147565
PMC: 6542842.
DOI: 10.1038/s41598-019-44336-7.
Kawamata M, Akimoto T, Sugase T, Otani-Takei N, Miki T, Masuda T
Clin Med Insights Case Rep. 2016; 9:21-4.
PMID: 26997878
PMC: 4795485.
DOI: 10.4137/CCRep.S36862.
Human leukocyte antigen alleles, genotypes and haplotypes frequencies in renal transplant donors and recipients from West Central India.
Patel J, Patel M, Koringa P, Shah T, Patel A, Tripathi A
Indian J Hum Genet. 2013; 19(2):219-32.
PMID: 24019626
PMC: 3758731.
DOI: 10.4103/0971-6866.116122.
Constraints on haplotype structure and variable gene frequencies suggest a functional hierarchy within cattle MHC class I.
Codner G, Birch J, Hammond J, Ellis S
Immunogenetics. 2012; 64(6):435-45.
PMID: 22454046
DOI: 10.1007/s00251-012-0612-6.
Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies.
Alpizar Y, Chain B, Collins M, Greenwood J, Katz D, Stauss H
Cancer Immunol Immunother. 2011; 60(8):1127-35.
PMID: 21479639
PMC: 11028423.
DOI: 10.1007/s00262-011-0985-7.
HLA class-II allele frequencies in Turkish breast cancer patients.
Gun F, Ozturk O, Polat A, Polat G
Med Oncol. 2011; 29(2):466-71.
PMID: 21373933
DOI: 10.1007/s12032-011-9873-4.
Genomic plasticity of the MHC class I A region in rhesus macaques: extensive haplotype diversity at the population level as revealed by microsatellites.
Doxiadis G, de Groot N, Otting N, Blokhuis J, Bontrop R
Immunogenetics. 2010; 63(2):73-83.
PMID: 20949353
PMC: 3019358.
DOI: 10.1007/s00251-010-0486-4.
HLA class II polymorphism: protective or risk factors to breast cancer in Tunisia?.
Baccar Harrath A, Loueslati B, Troudi W, Hmida S, Sedkaoui S, Dridi A
Pathol Oncol Res. 2006; 12(2):79-81.
PMID: 16799707
DOI: 10.1007/BF02893448.
Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin's gastric lymphoma patients.
Darom A, Gomatos I, Leandros E, Chatzigianni E, Panousopoulos D, Konstadoulakis M
World J Gastroenterol. 2006; 12(12):1924-32.
PMID: 16610000
PMC: 4087519.
DOI: 10.3748/wjg.v12.i12.1924.
HLA alleles and lung cancer in a Turkish population.
Ozbek N, Birinci A, Karaoglanoglu O, Coban A, Okumus B, Cakir S
Ann Saudi Med. 2004; 24(2):106-11.
PMID: 15323271
PMC: 6147902.
DOI: 10.5144/0256-4947.2004.106.
Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
Korkolopoulou P, Kaklamanis L, Pezzella F, Harris A, Gatter K
Br J Cancer. 1996; 73(2):148-53.
PMID: 8546899
PMC: 2074307.
DOI: 10.1038/bjc.1996.28.
Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines.
Browning M, Krausa P, Rowan A, Bicknell D, Bodmer J, Bodmer W
Proc Natl Acad Sci U S A. 1993; 90(7):2842-5.
PMID: 8464898
PMC: 46192.
DOI: 10.1073/pnas.90.7.2842.
Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.
Apasov S, Sitkovsky M
Proc Natl Acad Sci U S A. 1993; 90(7):2837-41.
PMID: 8464897
PMC: 46191.
DOI: 10.1073/pnas.90.7.2837.
Expression of beta 2-microglobulin by human benign and malignant mesenchymal and neurogenic tumours.
Petersen B, Braendstrup O
Int J Exp Pathol. 1993; 74(4):397-401.
PMID: 8398813
PMC: 2001843.
DNA content and MHC class II antigen expression in malignant melanoma: clinical course.
Zaloudik J, Moore M, Ghosh A, Mechl Z, Rejthar A
J Clin Pathol. 1988; 41(10):1078-84.
PMID: 3192729
PMC: 1141691.
DOI: 10.1136/jcp.41.10.1078.
Genetic analysis of HLA in the U.S. Schmiedenleut Hutterites.
Kostyu D, Ober C, Dawson D, Ghanayem M, Elias S, Martin A
Am J Hum Genet. 1989; 45(2):261-9.
PMID: 2757031
PMC: 1683340.
Altered growth of a human neuroendocrine carcinoma line after transfection of a major histocompatibility complex class I gene.
Sunday M, Isselbacher K, Willett C
Proc Natl Acad Sci U S A. 1989; 86(12):4700-4.
PMID: 2660144
PMC: 287339.
DOI: 10.1073/pnas.86.12.4700.